SALT LAKE CITY--(BUSINESS WIRE)--Freshmedx today announced the agreement to form a joint venture which will bring life saving technology to over 19 million people in Mexico who are at high risk of developing lung cancer. The Salt Lake City based medical device company, Freshmedx, has entered into an agreement with a prominent Mexican partnership to co-develop, market, sell and distribute its Bioconductance Scan Platform (BSP) system in Mexico.
